ArticleFEBS open bio2017

Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease.

Takako Mukai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.